Agoracom Blog Home

Posts Tagged ‘CSE’

Big Ten Universities Entering The New Esports Realm $GMBL.us

Posted by AGORACOM-JC at 11:05 AM on Friday, January 20th, 2017

Vgabmlinglarge copy

Members of Robert Morris University eSports teams practiced League of Legends in Chicago in 2014.CreditNathan Weber for The New York Times
  • In a recognition of the popularity of e-sports on college campuses, most Big Ten universities will field teams in the multiplayer online game League of Legends and compete in a style resembling conference play, in a partnership with the Big Ten Network.
  • Besides streaming competitions on the internet, the Big Ten Network will broadcast select games, including the championship in late March, weekly on its cable network, which is available to more than 60 million households nationally.

Riot Games, League of Legends’ creator and publisher, and the Big Ten Network — which is owned by Fox and the Big Ten Conference — announced the partnership Thursday morning in a joint statement. The Big Ten does not sponsor e-sports, which are not official N.C.A.A. sports.

In the first broadcast, on Jan. 30, teams from the Big Ten’s two newest members, Rutgers and Maryland, will face off, according to a Big Ten Network spokesman.

A number of popular games, including Madden-brand football video games, fall under the e-sports rubric. In League of Legends, two teams of five — composed of a set of stock characters seemingly inspired by fantasy novels — try to destroy a glowing object, called a nexus, on their opponent’s side.

In the Big Ten Network’s League of Legends season, teams in the Big Ten’s East and West divisions will play each other in best-of-three, round-robin competitions, and the top four from each division will then enter a single-elimination bracket. (The two Big Ten universities not participating this year, Nebraska and Penn State, are in different divisions. The Big Ten has 14 members.)

While lacking the mainstream visibility of traditional college sports, e-sports are wildly popular, even as spectator sports, among young people of the type sought after by both colleges and advertisers. Professional gaming contests frequently sell out major arenas, including Madison Square Garden, and several top European soccer clubs have signed e-sports playersas brand ambassadors.

Riot already runs a League of Legends College Championship, and the champion crowned by the Big Ten Network season will compete in the final rounds of that annual event.

Source: www.nytimes.com/2017/01/19/sports/big-ten-is-entering-a-new-realm-e-sports.html?smprod=nytcore-ipad&smid=nytcore-ipad-share&_r=0

Durango to Drill Test NMX East Lithium Project $DGO.ca

Posted by AGORACOM-JC at 10:30 AM on Wednesday, January 18th, 2017

Logo

  • Planning is underway to drill test its lithium bearing pegmatite zone discovered in the summer 2016 exploration program on ground adjacent to Nemaska Lithium’s (T-NMX) Whabouchi Deposit and the newly discovered Doris zone

Vancouver, BC / January 18, 2017 – Durango Resources Inc. (TSX.V-DGO), (the “Company” or “Durango”) announces that planning is underway to drill test its lithium bearing pegmatite zone discovered in the summer 2016 exploration program on ground adjacent to Nemaska Lithium’s (T-NMX) Whabouchi Deposit and the newly discovered Doris zone.

On January 17th, 2017 Nemaska Lithium announced “With the Doris zone discovery in late fall it is prudent to consider the possible impact of its eastward continuance…” In the news release of November 28th, 2016, Nemaska Lithium stated, “the Doris zone, contains 5 interconnected dykes and has now been confirmed on 420m of lateral extension and up to a maximum depth of 440m where it joins the main dyke.” “Doris appears to run parallel to main zone which extends for 1.2km to the northeast.”

Durango’s 100% wholly owned NMX East ground adjoins Nemaska Lithium on the eastern perimeter where Nemaska Lithium’s Doris zone remains open, less than 1.5km from the proposed mining pit. Durango’s geological team confirmed a pegmatitic intrusion running parallel to Nemaska Lithium’s main zone where it tested positive for anomalous Lithium and rubidium as per the news release on September 21, 2016. A map of the zones comparative with Nemaska Lithium Inc. may be viewed on the Durango website.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and the NMX East lithium property near the Whabouchi mine and the Buckshot graphite property near the Miller Mine in Quebec, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: durangoresourcesinc@gmail.com

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including, but not limited to timing of mineral resource estimates, future exploration or project development programs and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tetra Bio-Pharma CSO Discussing Task Force Recommendations, DEA — CFN Media $TBP.ca

Posted by AGORACOM-JC at 9:58 AM on Tuesday, January 17th, 2017

Tbp large

  • Exclusive interview covering the effect recent Canadian Cannabis Task Force recommendations and DEA actions could have on Tetra Bio-Pharma Inc.
  • United States government has permitted individual states to legalize the drug, but the Drug Enforcement Administration recently cracked down on cannabidiol (CBD) makers and President Trump’s cabinet picks are opponents of legalization

SEATTLE, WA–(Jan 17, 2017) – CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an exclusive interview and story covering the effect recent Canadian Cannabis Task Force recommendations and DEA actions could have on Tetra Bio-Pharma Inc. (OTC PINK: GRPOF) (CSE: TBP) as the company continues development of smokable marijuana as treatment for a variety of conditions.

The United States government has permitted individual states to legalize the drug, but the Drug Enforcement Administration recently cracked down on cannabidiol (CBD) makers and President Trump’s cabinet picks are opponents of legalization. In Canada, voters approved the nationwide legalization of cannabis with the election of Prime Minister Trudeau, but the framework governing the program is only now starting to become clear.

Tetra Bio-Pharma has already started down the pharmaceutical path by undergoing clinical trials for medical cannabis in its natural form. The company believes that smokable marijuana may provide patients with a better natural alternative to synthetic cannabinoids and extracts. With the large number of existing users, the company also has access to a lot of data to support its clinical studies.

In the interview, Tetra’s Chief Science Officer, Dr. Guy Chamberland, points out that medical cannabis patients are keen on receiving reimbursements since they cannot afford regular access without it. At the same time, physicians have been hesitant to prescribe medical cannabis without robust clinical trials demonstrating both safety and efficacy. These demands could lead to a much more ‘pharmaceutical’ approach than existing medical cannabis programs.

Please follow the link to read the full article and see the video interview: http://www.cannabisfn.com/tetra-biopharma-grpof-standing-on-the-right-side-of-regulation-plus-new-interview/

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media
CFN Media (CannabisFN), the leading creative agency and media network dedicated to legal cannabis, helps marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com

INTERVIEW: American Creek Discusses Treaty Creek JV Project Within Same Region as Pretivm’s Brucejack $AMK. Ca $PVG.ca

Posted by AGORACOM-JC at 9:21 AM on Monday, January 16th, 2017

  • American Creek Resources is a precious metals exploration company with an impressive portfolio of high-potential gold and silver projects in British Columbia.  These include properties in B.C.’s prolific Golden Triangle, one of the richest areas of mineralization in the world.
  • Treaty Creek claims area lies within the same broad hydrothermal system that generated the several deposits on the Seabridge Gold KSM and the Pretivm Brucejack properties that lie immediately southwest of the Treaty Creek claims
  • So far over 130 million ounces of gold, 800 million ounces of silver and 20 billion pounds of copper (all categories included), representing one of the greatest concentrations of metal value on the planet, have been delineated within the geological system shared by KSM, Brucejack, and Treaty Creek.

Hub On AGORACOM / Corporate Profile / Watch Interview

Namaste Purchases Earn-Out from VaporSeller $N.ca

Posted by AGORACOM-JC at 8:35 AM on Monday, January 16th, 2017

Nlogo

  • Entered into a binding amending agreement with Haze Industries, Inc. for the purchase of the remaining earn-out obligation
  • Initial undiscounted value of the earn-out was approximately US$1.5 million. Namaste will settle the remaining earn-out obligation of approximately US$1.3 million by making an initial payment of US$285,000 and monthly payments of US$8,000 for 12-months.

VANCOUVER, BRITISH COLUMBIA–(Jan. 16, 2017) - Namaste Technologies Inc. (“Namaste”) (CSE:N)(CSE:N.CN)(FRANKFURT:M5BQ) is pleased to announce that it has entered into a binding amending agreement (the “Amending Agreement”) with Haze Industries, Inc. (“Haze”) for the purchase of the remaining earn-out obligation as set forth in the definitive asset purchase agreement (the “Asset Purchase Agreement”) announced on June 7, 2016. The Asset Purchase Agreement memorialized the terms and conditions whereby Namaste purchased the assets comprising VaporSeller, an e-commerce platform for the distribution of vaporizers and accessories that is focused on the US market and generated an unaudited revenue of US$3.4 million in 2015. The initial undiscounted value of the earn-out was approximately US$1.5 million. Namaste will settle the remaining earn-out obligation of approximately US$1.3 million by making an initial payment of US$285,000 and monthly payments of US$8,000 for 12-months. Namaste will also issue Haze the initial tranche of 1,700,000 common shares of the Company pursuant to the Asset Purchase Agreement. The total number of shares to be issued is 5,000,000, as previously announced. All common shares issued will be subject to a 4-month statutory hold period.

Management Commentary

Sean Dollinger, President and CEO of Namaste, comments: “The purchase of this remaining earn-out obligation provides Namaste additional cash flow to reinvest into our operations. The VaporSeller customer list of over 150,000 individuals and domains represent a strong foothold for Namaste in the US market and we now control these assets without any future obligations. The principals of Haze will continue to work with Namaste as we assume full operational management of the site.”

About Namaste Technologies Inc.

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 e-commerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the company and its products can be accessed through the links below:

http://www.namastetechnologies.com/ http://www.vaporseller.com/
http://www.namastevaporizers.com/ http://www.everyonedoesit.com/
http://www.namastevaporizers.co.uk/ http://www.everyonedoesit.co.uk/

FORWARD LOOKING INFORMATION

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to several factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
+1 (786) 389 9771
info@namastevapes.com
www.namastetechnologies.com

HPQ Silicon Receives 43-101 Report on Beauce Gold Property and Prepares For Spin Out And Dividend In Q1 $HPQ.ca

Posted by AGORACOM-JC at 9:59 AM on Friday, January 13th, 2017

Hpq large

  • Received the required 43-101 Technical report for the Beauce Gold property, a prerequisite of the listing documentation for the planned spin-out of the company’s gold assets
  • Spin out and dividend of Beauce Gold Fields Expected by March 31, 2017

January 13, 2017 / Montreal, Quebec, Canada HPQ Silicon Resources Inc (“HPQ”) (TSX Venture: HPQ) is pleased to update shareholders regarding the status of its gold asset spinoff, as well as, announcing it has received the required 43-101 Technical report for the Beauce Gold property, a prerequisite of the listing documentation for the planned spin-out of the company’s gold assets.

UPDATE – SPIN OUT AND DIVIDEND OF BEAUCE GOLD FIELDS EXPECTED BY MARCH 31, 2017

On March 11, 2016, the company announced its plans to spin out its gold projects and issue a dividend to shareholders. The purpose of the spinout is to segregate the company’s valuable but diverse holdings to unlock even greater value for shareholders.

The Company will transfer all of its gold assets into a newly formed subsidiary called Beauce Gold Fields Inc./Les Champs d’Or de Beauce Inc., then dividend out 80% of the Capital of the subsidiary to its shareholders.

In order for the final transfer of Beauce from HPQ, the following steps have been taken:

1. An independent board of directors of the subsidiary Beauce Gold Fields Inc./Les Champs d’Or de Beauce Inc is in the process of being named. The new Board will be able to approve gold property transactions between Beauce and HPQ.

2. The Company has completed the required Listing Statement and prescribed documentation that will be submitted to the Canadian Securities Exchange (CSE) to be eligible for listing on the Exchange.

3. The completion of a new 43-101 on Beauce for the purposes of designating it the Property Of Merit for the new company.

HPQ-Silicon is aiming to have the spinoff completed and dividend shares of the new subsidiary delivered to shareholders during Q1 2017.

Bernard Tourillon, chairman and chief executive officer of HPQ Silicon stated: “We are very excited that the spin-out is nearing completion. We have seen a resurgence in the values of high quality gold projects and, given the fact the Beauce Gold project holds the largest historical placer gold deposit in eastern North America, we believe an independently traded Beauce Gold Fields will unlock meaningful value for our shareholders. Moreover, a singularly focused HPQ will provide an optimal environment to complete our goal of becoming the lowest cost producer of solar grade silicon metal on the planet.”

Beauce Gold 43-101 Technical Report

As part of the listing application documentation, the preparation and filing of a new 43-101 Qualification Technical report on the Beauce Gold property was required for it to become the Property Of Merit to Beauce Gold Fields.

The Company has received a 43-101 Technical report on the Beauce Gold property by Mr. Benoit Violette, P.Geo. Mr. Violette competed a full overview of the geology and of all historical and current exploration work. He concludes that in addition to the residual-alluvial mining potential for which the property is advanced in the permitting process, the Beauce Gold Project is a property of merit with a significant potential for the discovery of primary gold mineralization related to the source of the alluvial-residual deposits of the Gilbert River drainage. In the past, because of the relative ease of accessibility of the gold in this environment and the inexperience of the successive owners and operators with hard rock mining, this potential has been neglected. Further exploration is recommended to be carried-out by Beauce Gold Field Inc.

About The Beauce Gold Property

The Beauce Gold Project is a unique, historically prolific gold field located in the municipality of Saint-Simon-les-Mines in the Beauce region of Southern Quebec. Comprising of a block of claims 100% owned by HPQ Silicon, the project area hosts a six (6) km long unconsolidated gold bearing sedimentary units (a lower saprolite and an upper brown diamictite) holding the largest historical placer gold deposit in eastern North America. The gold in saprolite indicates a close proximity to a bedrock source of gold providing significant potential for further exploration discoveries.

Property Highlights

  • -Certificate of authorizations (CA) allowing the start of first phase mining activities on the Rang Chaussegros sector of the Beauce Gold project-Polygonally calculated Gold Exploration Target, for the entire historical placer channel ranging between 61,000 ounces (2,200,000 m3 @ 0.87 g Au/m3) and 366,000 ounces* (2,200,000 m3 @ 5.22 g Au/m3)-Significant potential for further exploration discoveries, geology suggest a proximate bedrock source of gold.-176 acres of real estate 100% owned by HPQ Silicon-Property held four historical gold mining operations-Property produced the largest gold nuggets in Canadian mining history (St-Onge Nugget 43 oz, McDonald Nugget 45 oz, Kilgour Nugget 51 oz)

For further information contact

Bernard J. Tourillon, Chairman and CEO Tel (514) 907-1011
Patrick Levasseur, President and COO Tel: (514) 262-9239
www.HPQSilicon.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Documents for AIM Exploration Inc. (USA) and AIM Exploration SA (Peru) and Prina Energy (India) have been completed and attested by the respective governments $AEXE.us

Posted by AGORACOM-JC at 3:31 PM on Thursday, January 12th, 2017

1a93cd37a17b71f3562bd2343552

  • Legal documents for both AIM Exploration Inc. (USA) and AIM Exploration SA (Peru) and Prina Energy (India) have been completed and attested by the respective government agencies
  • Documents are in Dubai and have been submitted to MOFA (Ministry of Foreign Affairs) in Dubai for final attestation.
  • High demand Continues for Anthracite Coal

HENDERSON, NV / January 12 , 2017 / AIM Exploration Inc. (OTCQB: AEXE) is excited to announce that all legal documents for both AIM Exploration Inc. (USA) and AIM Exploration SA (Peru) and Prina Energy (India) have been completed and attested by the respective government agencies. The documents are in Dubai and have been submitted to MOFA (Ministry of Foreign Affairs) in Dubai for final attestation.

This is the final step required before being submitted to the DMCC in Dubai to set up the joint venture marketing arm for AIM Exploration Inc. The company is expected to be named AIM Exploration DMCC.

Once this is set up, AIM will be well positioned to commence the marketing which AIM is positioned to execute. Mr. Karan Dhaliwal, CEO of Joint Venture company AIM Exploration DMCC, has been in Dubai working diligently to get all of this accomplished. As soon as the joint venture corporation is in place, it is expected that AIM will move very quickly to secure long-term contracts to supply high-grade anthracite coal to companies that have shown a great deal of interest in working with AIM.

We welcome our audience to view our website: http://aimexploration.com

And we also welcome people to follow our twitter feed at www.twitter.com/aexeqb, which has 5000 followers and growing. “This gives us indication that clean energy is a global concern and enforces our belief that that is why we need to carry out our objective of mining clean high BTU anthracite coal,” says J.R. (Bob) Todhunter.

About Aim Exploration:

The Company is a Anthracite coal mining and exploration company and plans to mine 1,000 hectares of land. Putting this into perspective, 1,000 hectares is 3 times the size of Central Park. We have expertise in business, mining, and legal with our distinguished board of directors. We have amicable relationships with all parties involved in mining in Peru. We are a SEC reporting publicly traded company with the symbol (OTCQB: AEXE).

Forward-Looking Statements

Certain information set forth in this press release contains “forward-looking statements” and “forward-looking information” under applicable securities laws. Except for statements of historical fact, certain information contained herein constitutes forward-looking statements, which include management’s assessment of future plans and operations and are based on current internal expectations, estimates, projections, assumptions, and beliefs, which may prove to be incorrect. the Company is not basing its production on a feasibility study of mineral reserves that has demonstrated economic and technical viability. Also, please provide additional disclosure of the increased uncertainty and the specific economic and Some of the forward-looking statements may be identified by words such as “estimates,” “expects,” “anticipates,” “believes,” “projects,” “plans,” “targets,” and similar expressions. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause AIM’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements.

Contact:

info@aimexploration.com
Twitter: www.twitter.com/aexeqb or @aexedb
Website: www.aimexploration.com
AIM Exploration Inc.
J.R. (Bob) Todhunter

Tetra Bio-Pharma Inc. Announces New Appointment of Dr. Gilles Chamberland, M.D., FRCPC to its Scientific and Clinical Advisory Board $TBP.ca

Posted by AGORACOM-JC at 9:15 AM on Wednesday, January 11th, 2017

Tbp large

  • Announced the nomination of Dr. Gilles Chamberland, MD, FRCPC, to its Scientific and Clinical Advisory Board
  • Board is comprised of experts in clinical research, pain management, cancer, and neurological product drug development

(TORONTO, ONTARIO  Jan. 11, 2017) - PhytoPain Pharma Inc. (“PhytoPain Pharma” or “PPP“), a subsidiary of Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), is pleased to announce the nomination of Dr. Gilles Chamberland, MD, FRCPC, to its Scientific and Clinical Advisory Board. The board is comprised of experts in clinical research, pain management, cancer, and neurological product drug development. The nomination of Dr. Chamberland, M.D., to its Advisory Board will provide critical guidance on PPP’s clinical development program with regards to the safety of cannabis drug products and the potential mental health risks associated with the consumption of marijuana.

“Patient safety has been a driving force since the creation of PPP. The use of cannabis has been associated with several important safety issues including potential psychiatric-related events. As a company focused on creating scientific data these risks, as well as others, must be adequately assessed and quantified in a clinical environment. The addition of Dr. Gilles Chamberland, M.D., FRCPC, to our team of accomplished scientific and clinical experts will help us ensure that these potential adverse effects of consuming cannabis will be adequately assessed in our clinical development program and these potential risks will be appropriately communicated to both physicians and patients”, stated Dr. Guy Chamberland, Chief Scientific Officer and Regulatory Affairs.

ABOUT Dr. Gilles Chamberland

Dr. Gilles Chamberland, M.D., FRCPC – Director Professional Services, Medical Psychiatrist, Associate Professor, Department of Psychiatry, Institut Philippe-Pinel de Montréal, Université de Montréal.

Dr. Chamberland received a Bachelor of Law degree from the Université de Sherbrooke, a doctorate in medicine from the Université de Montréal, a diploma in psychiatry from the Université de Montréal, and a diploma of advanced studies in biological and medical ethics of the René Descartes University in Paris. In 2012, he earned the Distinguished Fellow from the Canadian Psychiatric Association and, by 2015 the American Psychiatric Association gave him the same professional recognition. He received a diploma in the subspecialty of Forensic Psychiatry in 2013 from the Royal College of Physicians and Surgeons of Canada. Dr. Chamberland has a vast experience in clinical management of patients suffering from various psychiatric conditions including marijuana induced-psychosis. He is also a well-known author and expert witness in the field on psychiatry.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Tetra Bio-Pharma Inc.
Andre Rancourt, Chief Executive Officer, or
Ryan Brown. VP Business Development and Communications, or
Andre Audet, Executive Chairman
(343) 689-0714
Investors@tetrabiopharma.com

Explor Announces Multiple Copper Zones Grades Up to 3.65% Cu Over 5.35 Meters on the Chester Copper Property $EXS.ca

Posted by AGORACOM-JC at 5:02 PM on Tuesday, January 10th, 2017

Exs logo


  • 12 Diamond Drill Holes completed on the Chester Copper Property
  • 3.65% Cu Over 5.35 Meters
  • increase in strike length of the known mineralization from 500 to 750 meters

ROUYN-NORANDA, QUEBEC–(Jan. 10, 2017) - Explor Resources Inc. (“Explor” or the “Corporation“) (TSX VENTURE:EXS)(OTCQB:EXSFF)(FRANKFURT:E1H1)(BERLIN:E1H1) is pleased to announce further results from the 12 Diamond Drill Holes completed on the Chester Copper Property. The Chester Copper property is located in the Northumberland County, 70 km southwest of Bathurst, New Brunswick and 50 km west-northwest of Miramichi, New Brunswick, within the Bathurst Mining Camp. This area has an extensive history in base metal production from VMS deposits.

There has been very little exploration work in this area of the Bathurst Mining Camp (BMC) since the initial exploration more than 60 years ago. Of significance also is the fact that three (3) age date studies of the rock in the area since 2005 have indicated an age of 469+/- 0.3 ma. All of the main largest VMS deposits in the BMC (including BMS #12 and #6, the Caribou Deposit (currently being developed by Travalli) and the past producing Heath Steele Mines, are associated with this age date for the footwall felsic rocks. That new data in 2007 places Explor’s Chester deposit is in the same time frame as the Brunswick Mining No. 12 and No. 6 deposits located in the BMC.

New Brunswick is the home of the No 12 massive sulphide deposit (The Brunswick Deposit) which was in continuous production from 1964 to its closure in March of 2013 (to Feb 2013, 135,903,168 tonnes milled at 3.44 % Pb, 8.74 % Zn, 0.37 % Cu and 102 g/t Ag). The Brunswick deposits (No 6 and No 12) are situated in the Nepisiguit Falls Group of rocks in the Lower Tetagouche group of the BMC. There are 46 known VMS deposits in the BMC.

The property is located in the southern-most part of the Bathurst Mining Camp and consist of 174 Mineral Claim Units within a total of five (5) Mineral Claims (1571, 2428, 6003, 6005 and 7045) comprising approximately 3,828 hectares as shown on the attached map.

Chris Dupont, President and Chief Executive Officer of Explor Resources Inc. commented: “We are extremely pleased and encouraged by these preliminary drill results. The presence of multiple copper mineralized zones in each of the holes drilled is very significant in terms of exploration. The increase in strike length of the known mineralization from 500 to 750 meters confirms the potential to significantly increase the resources on the property. The property continues to be open on strike to the west and Northwest.”

A total of 4 diamond drill holes were drilled on claim 1571. The first three diamond drill holes that were drilled were fan holes from the same location. This successfully tested the extension of the copper stringer zone for a distance of 250 meters west of previous drilling. The fourth drill hole was located approximately 100 meters west (and 38 meters south) of the first three drill holes, confirming the continuity of the mineralization to the west and Northwest and adding 250 meters of strike length to the known deposit. It intersected the target horizon and favorable geology from 49 meters to 172 meters.

Further to the west the copper deposit goes down dip and onto claim 6003. At about 1,100 meters west of the first drill hole, drill hole 6003-16-012 was drilled at a vertical dip. It eventually went to a depth of 600 meters and intersected previously unknown mineralization near surface (18 meters) and also extending the deep main Chester Stringer zone an additional 650 meters westward than any previous reliable drilling (i.e. casing in place and core in government storage). It also confirms the existence of the alteration zone and the host stratigraphic horizon to a depth not previously known or expected. The chloritized favorable horizon extends from a depth of 472.5 meters to 561 meters with low grade copper mineralization documented from 519 meters to 543 meters.

In the north part of claim 6003, an untested soil geochemical anomaly was tested. Copper mineralization was discovered as pyrrhotite and chalcopyrite veinlets in felsic volcanic associated with the soil anomaly. Copper mineralization was also discovered in this area in 2014 and a soil survey on claim 7045 to the west have unexplained copper and lead anomalies which may be associated with previously mentioned soil anomaly and this horizon.

To the south on Claim 6005, two drill holes were put down to test a soil anomaly apparently associated with a historical drill hole, dating to about the 1956 to 1958 era, with a reported value of more than 2% copper. No indication of any mineralization was discovered in the two drill holes.

Preliminary results are shown below for Hole # 1571-16-002:

Summary of Results From Drill Hole 1571-16-002
Zones From
(m)
To
(m)
Length
(m)
Au
(ppb)
Ag
(ppm)
Cu
(%)
Zn
(ppm)
Pb
(ppm)
1 49.40 49.73 0.33 41 2.70 1.820 269 67
2 51.45 52.30 0.85 49 2.40 1.240 284 80
3 77.85 84.30 6.45 65 3.35 1.53 438 57
includes 77.85 80.70 2.85 47 2.78 1.18 350 61
and 80.70 81.93 1.23 28 1.60 0.18 401 48
and 81.93 84.30 2.37 105 4.94 2.66 562 56
4 112.90 113.30 0.40 105 9.6 7.111 439 49
5 121.00 127.00 6.00 82 3.92 3.20 381 43
includes 121.00 125.10 4.10 114 4.99 4.26 469 43
or 124.10 125.10 1.00 289 10.10 10.23 1014 76
and 126.05 127.00 0.95 26 2.60 1.70 276 62
6 141.80 142.90 1.10 114 3.55 2.889 317 40
142.90 151.10 8.20 3,6 0.16 0.065 59 21
7 151.10 151.85 0.75 34 2.8 2.130 252 26
FW Zone 171.5 171.85 0.35 50 3.2 1.580 214 42

A total of 8 zones of copper mineralization were intersected in the above referenced Hole # 1571-16-002.

Preliminary results are shown below for Hole # 1571-16-003:

Summary of Results From Drill Hole 1571-16-003
Zones From
(m)
To
(m)
Length
(m)
Au
(ppb)
Ag
(ppm)
Cu
(%)
Zn
(ppm)
Pb
(ppm)
1 58.10 58.57 0.47 28 4 1.760 586 52
2 64.00 70.80 6.80 42 4.3 1.45 565 106
includes 64.00 67.10 3.10 39 6.0 2.09 660 186
or 65,50 67.10 1.60 75 11.5 4.05 1279 360
and 69,90 70.80 0.90 139 7.0 3.05 1033 58
3 77.70 78.60 0.90 76 2.4 1.220 328 44
4 112.65 112.85 0.20 60 6.7 4.330 592 42
5 115.25 120,60 5.35 64 4.9 3.65 445 49
includes 115.25 117.40 2.10 47 4.6 3.25 372 39
and 117.40 120.,60 3.20 76 5.2 3.97 501 56
FW Zone 157.30 158.85 1.55 343.10 15.00 13.20 995.00 91.13

A total of 6 zones of copper mineralization were intersected in the above referenced Hole # 1571-16-003. Samples have been sent to the lab and assays are pending.

The Chester Property is known to contain both a copper deposit and a VMS deposit. The copper deposit has an Open Pit resource with Measured & Indicated resource of 1,400,000 tonnes grading 1.38% Cu, 0.06% Zn & 3.5 g/t Ag and an inferred resource of 2,089,000 tonnes grading 1.26% Cu (assayed for Cu only).

Chris Dupont, P.Eng is the qualified person responsible for the information contained in this release.

Explor Resources Inc. is a publicly listed company trading on the TSX Venture (EXS), on the OTCQB (EXSFF) and on the Frankfurt and Berlin Stock Exchanges (E1H1).

This Press Release was prepared by Explor. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the Policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this release.

About Explor Resources Inc.

Explor Resources Inc. is a Canadian-based natural resources company with mineral holdings in Ontario, Québec, Saskatchewan and New Brunswick. Explor is currently focused on exploration in the Abitibi Greenstone Belt. The belt is found in both provinces of Ontario and Québec with approximately 33% in Ontario and 67% in Québec. The Belt has produced in excess of 180,000,000 ounces of gold and 450,000,000 tonnes of cu-zn ore over the last 100 years. The Corporation was continued under the laws of Alberta in 1986 and has had its main office in Québec since 2006.

Explor Resources Flagship project is the Timmins Porcupine West (TPW) Project located in the Porcupine mining camp, in the Province of Ontario. Teck Resources Ltd. is currently conducting an exploration program as part of an earn-in on the TPW property. The TPW mineral resource (Press Release dated August 27, 2013) includes the following:

Open Pit Mineral Resources at a 0.30 g/t Au cut-off grade are as follows:

Indicated: 213,000 oz (4,283,000 tonnes at 1.55 g/t Au)
Inferred: 77,000 oz (1,140,000 tonnes at 2.09 g/t Au)

Underground Mineral Resources at a 1.70 g/t Au cut-off grade are as follows:

Indicated: 396,000 oz (4,420,000 tonnes at 2.79 g/t Au)
Inferred: 393,000 oz (5,185,000 tonnes at 2.36 g/t Au)

This document may contain forward-looking statements relating to Explor’s operations or to the environment in which it operates. Such statements are based on operations, estimates, forecasts and projections. They are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and may be beyond Explor’s control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements, including those set forth in other public filling. In addition, such statements relate to the date on which they are made. Consequently, undue reliance should not be placed on such forward-looking statements. Explor disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.

To view the image associated with this press release, please visit the following link: http://media3.marketwire.com/docs/1082322a.pdf

Christian Dupont, President
888-997-4630 or 819-797-4630
819-797-1870
www.explorresources.com
info@explorresources.com

Tetra Bio-Pharma Inc. Announces Binding Letter of Intent for JV Co-Development and Commercialization of Health Care Products Containing Cannabinoids also Closes Private Placement $TBP.ca

Posted by AGORACOM-JC at 9:03 AM on Tuesday, January 10th, 2017

Tbp large

  • Entered into a binding letter of intent to form a joint venture with Ford’s Family Pharmacy and Wellness Center (“FFP”) in Moncton, New Brunswick
  • Primary objective of this venture is the development and commercialization of cannabinoid-based products for the Canadian health care market with a special focus on CBD and THC-free cannabis products for the USA cosmetic and supplement market

OTTAWA, ONTARIO–(Jan. 10, 2017) - Tetra Bio-Pharma Inc. (“TetraBio“, “TBP“, or the “Company“) (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GROPF) through its subsidiary, Agro-Tek Health Inc. (“GTK“), is pleased to announce that it has entered into a binding letter of intent to form a joint venture with Ford’s Family Pharmacy and Wellness Center (“FFP“) in Moncton, New Brunswick. The primary objective of this venture is the development and commercialization of cannabinoid-based products for the Canadian health care market with a special focus on CBD and THC-free cannabis products for the USA cosmetic and supplement market.

About Tetra Bio-Pharma

Tetra Bio-Pharma, through its subsidiaries, is engaged in the development and commercialization of cannabis-based pharmaceuticals and consumer health products. www.tetrabiopharma.com

About Agro-Tek Health

Agro-Tek Health is a subsidiary of Tetra Bio-Pharma Inc. and is focused on commercialization of over the counter consumer goods containing cannabis and other non-controlled medicinal plants.

About Ford’s Family Pharmacy

Ford’s Family Pharmacy and Wellness Center currently holds a Controlled Substance License from Health Canada for the processing, packaging, and distribution of controlled substances. https://www.fordrx.com

Since 1997, Ford’s Family Pharmacy & Wellness Centre has helped clients improve and prolong their health, wellness, and vitality by providing personalized compounding and wellness solutions. Their team consists of: four pharmacists, 14 pharmacy technicians/assistants and two registered nurses. FFP provides innovative solutions to complex medical problems and works with Canadian healthcare providers (including physicians, veterinarians, and dentists) to create well-rounded, comprehensive natural and compounding treatment plans.

To maximize the benefit of this venture, GTK will establish its health care product development and commercialization activities within the province of New Brunswick. New Brunswick is quickly positioning itself as a desired homebase for companies in the cannabis industry and GTK commends the government of New Brunswick for its assistance in establishing this project.

Dr. Peter Ford, Pharm D will work with GTK to develop cannabinoid-based skin care and wellness products for the Canadian retail markets. This joint venture will allow GTK to develop a portfolio of innovative CBD-based products for patient self-care in addition to CBD and THC-free products for the USA cosmetic and supplement market.

According to Mr. André Rancourt, Chief Executive Officer, “These products will allow GTK to commercialize cannabis-derived products for the Canadian and USA wellness market in preparation for the unveiling of Canada’s new cannabis regulations.”

Dr. Ford will also assist TetraBio with its ongoing NSERC Engage partnership grant with McGill University (see press release from October 19, 2016). Dr. Ford’s expertise will also be used for the development of the PPP001 dried cannabis pellets for upcoming phase 1 clinical trials. “The partnerships with McGill University and Dr. Ford are in line with the Company’s vision to expand its commercial operations focused on the development and sale of cannabis-derived supplements and retail products for the North American market,” commented Mr. Rancourt.

Dr. Guy Chamberland, M.Sc., Ph.D., Chief Science Officer, commented, “Ford’s Family Pharmacy and Wellness Center currently holds a Controlled Substance License from Health Canada for the processing, packaging, and distribution of controlled substances. Working with Dr. Ford will allow TBP to adhere to current regulations relating to controlled substances including cannabis. This resource allows TBP to further its ongoing projects while remaining compliant with Canadian and US narcotics regulations.” He also stated, “Dr. Ford is a renowned expert in wellness and a highly-experienced formulator and this joint venture will help the Company bring cutting edge cannabis-based health and wellness products to patients and consumers in a timely and cost effective manner.”

This project will be funded via current working capital and the previously announced NSREC research grant in collaboration with McGill University.

Closing of Non-brokered Private Placement

The Company is also pleased to announce that, on December 30, 2016, it closed a non-brokered private placement of 2,395,500 units at a price of $0.20 per unit for aggregate gross proceeds of $479,100. Each unit consists of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $0.26 per share for a period of twelve months expiring December 30, 2017.

The securities issued pursuant to the private placement are subject to a four-month hold period from the closing date and subject to all necessary regulatory approvals, including the approval of the Exchange.

The proceeds of the private placement will be used to pursue commercialization projects in 2017 and increase scientific staff.

In Other News

Tetra Bio-Pharma is also pleased to announce that, effective December 16, 2016, TBP has been added to the Canadian Securities Exchange composite index. The index is comprised of listed companies that meet market capitalization, trading, and seasoning criteria established by the exchange.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer
343-689-0714

Tetra Bio-Pharma Inc.
Dr. Guy Chamberland
Chief Scientific Officer
343-689-0714
www.tetrabiopharma.com